Pacemakers Market Trends, Size, Share, Growth by Forecast to 2027
According to The Insight Partners market research study titled ‘Pacemakers Market - Global Analysis and Forecasts by Product Type, Technology and End User. The global pacemakers market is expected to reach US$ 10,908.0 Mn in 2027 from US$ 5,485.4 in 2018. The market is estimated to grow with a CAGR of 8.1% from 2019-2027. The report highlights the trends prevalent in the global pacemakers market and the factors driving the market along with those that act as deterrents to its growth.
Browse More Details on Report at: https://www.theinsightpartners.....com/reports/pacemak
The pacemakers market by product type is segmented into implantable pacemakers and external pacemakers. In 2018, the implantable pacemakers segment held the largest share of the market, by product type. Moreover, the same segment of pacemakers market is also expected to witness growth in its demand at a fastest CAGR of 8.4% during 2019 to 2027. The spurring adoption of these devices relies majorly on the availability of reimbursement that results in reducing the economic burden on the patients in the developed economies that have high prevalence of cardiovascular diseases.
Key factors driving the market are increasing burden of cardiovascular diseases, increasing technological advancements and large pool of geriatric population. However, high cost of implantation procedures and product recalls for pacemakers are likely to refrain the market growth. Additionally, the future trends such as product innovations are likely to increase the growth of the pacemaker market in the forecasted period.
Some of the prominent players operating in pacemakers market are, Medico S.p.A., Vitatron, Abbott, Medtronic, OSCOR, LivaNova Plc, Abiomed, Boston Scientific Corporation, Biotronik, Zimmer Biomet, and Lepu Medical among others. The market players are focused towards bringing new and innovative products to sustain their position in the market. For instance, In August 2017, BIOTRONIK introduced smallest MR conditional CRT-P named Edora HF-T QP for patients suffering with heart failure. The launch is likely to help company complement its pacemakers’ portfolio as well as account for revenue growth.
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
